CSL Behring at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

CSL Behring takes part in 2 sessions at BIO-Europe 2026 in Cologne. Its sessions cover partnering and business development in a shifting global landscape, and regulatory sandboxes as a way to bring novel therapeutics and technologies forward. CSL Behring also sponsors the meeting.

OrganizationBIO-Europe 2026 Attendance
CSL Behring
King of Prussia, PA
◆Platinum Sponsor
Large pharmaPlatinum sponsor
CSL's biotherapeutics business, making plasma-derived and recombinant therapies for rare and serious diseases.
Panel
Mon Nov 9
13:00–14:00
Navigating partnering and business development in a shifting global landscape
How funding conditions, treatment trends and geopolitics are shaping partnerships and acquisitions between drug and biotech companies, with real deal examples.
with Syneos Health, Abingworth, Genmab +2 more
Panel
Tue Nov 10
14:00–14:45
Harnessing Regulatory Sandboxes to Drive Innovation in Novel Therapeutics & Technologies
How regulatory sandboxes, where regulators let new products be tested under adjusted rules, could support new therapies and health technologies in Europe.
with HTW Berlin, Innovative Health Initiative, European Medicines Agency

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from CSL Behring

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by EBD Group, Informa Connect or BIO-Europe. Submit a correction